FEB 03, 2017 6:21 PM PST

Stem Cells Successfully Deliver Therapeutics to Brain Cancer

WRITTEN BY: Carmen Leitch

Scientists at the University of North Carolina at Chapel Hill have made another incredible advancement in their study of cancer therapeutics. After successfully using a mouse model to demonstrate that stem cells had the potential to target and destroy cancer cells, they have applied their work to human cells. Reporting in Science Translational Medicine, the researchers showed that stem cells grown from human skin cells can be modified into cancer fighting machines, and quickly enough to come to the aid of patients. You can get an overview of the work from the video below.

Shawn Hingtgen, a UNC Assistant Professor in the Eshelman School of Pharmacy and member of the Lineberger Comprehensive Cancer Center, led the team that first reported this technique last year; survival time in various types of brain cancer increased 160 to 220 percent in mouse models of different types of tumors. This new work confirms that human skin cells be used in this same way, and shows that the cells can be harvested and modified fast enough to help people that have only a 30 percent chance of surviving for two years past diagnosis.

"Speed is essential," Hingtgen said. "It used to take weeks to convert human skin cells to stem cells. But brain cancer patients don't have weeks and months to wait for us to generate these therapies. The new process we developed to create these stem cells is fast enough and simple enough to be used to treat a patient."

Glioblastoma patients have only chemotherapy, radiation and surgery as treatment, and in most patients tumors that are shrunk only end up returning within months. The tumors can't be seen by a surgeon or reached by drugs, making them virtually impossible to completely remove, explained study co-author Ryan Miller, a neuropathologist at UNC Hospitals and Associate Professor at the UNC School of Medicine.

"We desperately need something better," said Hingtgen.

A method, skin-flipping, that won the Nobel Prize in 2012 was the foundation for this work. The process involves collecting skin cells that make collagen and connective tissue, fibroblasts, from a patient. Those cells are then reprogrammed. In cellular reprograming, four genes are introduced into the cells, and in a bit of nature's magic, the cells then become pluripotent stem cells that have the power to become any cell in the body. But all of the details of how that happens are not understood. Scientists simply know it works, and use the methodology. In this case the cells are reprogrammed into neural stem cells, and they are able to zero in on brain cancer cells.

These stem cells normally don't kill cancer by themselves, they only locate it and get near it. So the scientists had to do a bit more engineering to transmit agents that can be used by the cells for combating the cancer. The team has thus developed stem cells that transmit a protein, which acts on a substance given to the patient, an inert prodrug. Then the drug only becomes activated in the presence of the cells that carry the activating protein, and the drug isn't circulating throughout the entire body (and causing unintended and noxious side effects).

"We're one to two years away from clinical trials, but for the first time, we showed that our strategy for treating glioblastoma works with human stem cells and human cancers," said Hingtgen. "This is a big step toward a real treatment -- and making a real difference."

 

Sources: AAAS/Eurekalert! via University of North Carolina at Chapel Hill, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 27, 2020
Cell & Molecular Biology
Using Antibodies & Oligonucleotides to Control Specific Reactions
DEC 27, 2020
Using Antibodies & Oligonucleotides to Control Specific Reactions
Antibodies are naturally used by the body to bind targets on pathogens and neutralize them, and these specific interacti ...
JAN 08, 2021
Cell & Molecular Biology
How Viruses Keep the Infection Going
JAN 08, 2021
How Viruses Keep the Infection Going
There has long been debate about whether viruses are a form of life, because many of them are only made up of a bit of g ...
JAN 17, 2021
Cell & Molecular Biology
How a Nutrient Can Aid in Infection Prevention
JAN 17, 2021
How a Nutrient Can Aid in Infection Prevention
Antibiotic-resistant microbes are considered to be a serious threat to public health, one of many reasons why it's impor ...
JAN 24, 2021
Cell & Molecular Biology
A Protein That Restores Muscle Function and Doubles Capacity in Aged Mice
JAN 24, 2021
A Protein That Restores Muscle Function and Doubles Capacity in Aged Mice
Scientists have identified a hormone that is generated during exercise, and they determined that when mice are treated w ...
FEB 09, 2021
Cell & Molecular Biology
Brain Cells Called Astrocytes Linked to Depression
FEB 09, 2021
Brain Cells Called Astrocytes Linked to Depression
Depression is thought to affect at least 264 million people of all ages worldwide, and the available treatment options d ...
FEB 18, 2021
Cell & Molecular Biology
Inhibition of a Specific Enzyme Could be a Way to Treat Glioblastoma
FEB 18, 2021
Inhibition of a Specific Enzyme Could be a Way to Treat Glioblastoma
Researchers may have identified a new treatment target for a deadly form of brain cancer. Inhibiting an enzyme called PR ...
Loading Comments...